Random Lopinavir Concentrations Predict Resistance on Lopinavir-Based Antiretroviral Therapy

International Journal of Antimicrobial Agents - Netherlands
doi 10.1016/j.ijantimicag.2016.04.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/R Based Antiretroviral Therapy

PLoS ONE
Multidisciplinary
2013English

Metabolic Abnormalities and Body Composition of HIV-infected Children on Lopinavir or Nevirapine-Based Antiretroviral Therapy

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2012English

Lopinavir Is a Substrate for SLCO1A2 but 516A>C and 38T>C Polymorphisms Do Not Influence Lopinavir Plasma Concentrations

Journal of the International AIDS Society
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2008English

Lopinavir/Ritonavir Monotherapy After Virologic Failure of First-Line Antiretroviral Therapy in Resource-Limited Settings

AIDS
Infectious DiseasesAllergyImmunology
2012English

Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy Before the Age of Two in Cote D’Ivoire

PLoS ONE
Multidisciplinary
2016English

The Frequency of Malaria Is Similar Among Women Receiving Either Lopinavir/Ritonavir or Nevirapine-Based Antiretroviral Treatment

PLoS ONE
Multidisciplinary
2012English

Long-Term Safety and Effectiveness of Lopinavir/Ritonavir in Antiretroviral-Experienced HIV-1-infected Children

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2010English

Efficacy and Tolerability of Lopinavir/Ritonavir- And Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China

Frontiers in Pharmacology
Pharmacology
2019English

Lopinavir/Ritonavir Population Pharmacokinetics in Neonates and Infants

British Journal of Clinical Pharmacology
Pharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy